If you had seen what I have seen you would think twice before rejecting positive views as "bias."
Please read this carefully, do a bit of research on the connections of NF-kB and inflammation with a long list of diseases, then ask yourself if people who benefited from anatabine citrate were necessarily just imagining things.
Pay close attention to "cholinergic agonist" - it's important. Notice what drugs anatabine citrate might displace (in part or whole) in the market: "biologics, steroids and non-steroidal anti-inflammatories." This may be important too. It might explain a lot of what has happened.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.